A former colorectal-cancer diagnostics company reborn as an autonomous defense platform maker — LOIs signed, factory acquired, but no contracts, no revenue, and no disclosed cash runway

Updated 62d ago

Mainz Biomed is an early-stage defense company that makes autonomous drone systems, which are not yet approved, and whose survival depends on converting preliminary government interest into actual contracts before its cash runs out.

Mainz Biomed abandoned colorectal cancer diagnostics entirely in early 2026 and reincorporated as Quantum Cyber, a drone defense company with no approved products and no prior defense revenue. The bet resolves on whether SWARM-X and FALCON 55 LOIs convert to binding government contracts before cash from the $15M warrant exercise is exhausted. Cash position and burn rate are undisclosed, making survival to first delivery impossible to verify.

Status

Challenged

Conviction

Current Thesis Drivers

SWARM-X and FALCON 55 LOIs signed, unit pricing specified
Bridgeport 50,000 sq ft facility owned, $2.3M acquisition closed
FOCI clearance decision outstanding, contracting vehicle unactivated
Cash position and burn rate entirely undisclosed post-$15M warrant exercise

What could change the thesis?

FOCI clearance decision: granted unlocks contracts, denied strands LOIs
LOI-to-contract conversion: signed reopens bull case, lapsed ends revenue thesis
Cash disclosure: runway confirmed holds thesis, inadequate burns it

Generated from public SEC filings and disclosures. For informational purposes only — not investment advice. Always conduct your own research before making investment decisions.

Thesis log

Tracked in real time as it happened — not reconstructed after the fact

Key value driver

The most decisive event ahead

Bull and bear case

Both sides of the thesis, argued

Pipeline

0 programs · 8 catalysts

Stress Test